Kovack Advisors Inc. Sells 99,901 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Kovack Advisors Inc. cut its holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 44.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 123,875 shares of the company’s stock after selling 99,901 shares during the quarter. Kovack Advisors Inc. owned about 0.15% of Stereotaxis worth $253,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of Stereotaxis by 7.7% during the 1st quarter. Vanguard Group Inc. now owns 2,613,966 shares of the company’s stock valued at $6,822,000 after acquiring an additional 187,437 shares during the last quarter. Renaissance Technologies LLC boosted its position in Stereotaxis by 46.2% during the second quarter. Renaissance Technologies LLC now owns 488,700 shares of the company’s stock worth $889,000 after purchasing an additional 154,400 shares during the period. Bank of New York Mellon Corp grew its holdings in Stereotaxis by 247.5% during the second quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock valued at $345,000 after purchasing an additional 135,041 shares during the last quarter. Rhumbline Advisers raised its position in shares of Stereotaxis by 645.6% in the second quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock valued at $88,000 after purchasing an additional 41,780 shares during the period. Finally, Virtu Financial LLC lifted its stake in shares of Stereotaxis by 56.0% in the first quarter. Virtu Financial LLC now owns 32,690 shares of the company’s stock worth $85,000 after buying an additional 11,739 shares during the last quarter. 45.35% of the stock is owned by institutional investors.

Stereotaxis Stock Performance

Stereotaxis stock opened at $2.03 on Friday. Stereotaxis, Inc. has a 52 week low of $1.47 and a 52 week high of $3.29. The stock has a market capitalization of $171.86 million, a PE ratio of -7.25 and a beta of 1.55.

Stereotaxis (NYSEAMERICAN:STXS) last announced its earnings results on Monday, November 11th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). Stereotaxis had a negative return on equity of 153.10% and a negative net margin of 85.79%. The company had revenue of $9.20 million for the quarter, compared to the consensus estimate of $6.80 million. Analysts anticipate that Stereotaxis, Inc. will post -0.25 EPS for the current year.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.